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ABSTRACT  
Objective: To investigate the knowledge and perceptions of final-year medical students in the Yemeni universi-
ties about generic medicines. 
Methods: A two-month cross-sectional survey was conducted among final-year medical students in three Yem-
eni universities; Sana’a University, University of Science and Technology and Thamar University in 2013. 
Results: One hundred and sixty-five medical students out of 270 responded to the present study, with a re-
sponse rate of 61.1%. More than 60% of medical students were not introduced to bioequivalence of generic 
medicines during their undergraduate study, and 80.0% of them had a low desire to inquire about it during their 
study. In addition, more than 60.0% of them were unaware of the similarity of generic medicines to their brand 
equivalents in dosage form and dose. More than three-quarters of the medical students incorrectly perceived 
that generic medicines are inferior in quality (80.0%), less effective (58.0%) and with more side-effects (47.8%) 
than their brand equivalents. The medical students in the present disagreed about the need for more infor-
mation on the safety and efficacy of generic medicines.  
Conclusions: Yemeni students need to further enhance their awareness and expand their knowledge about the 
concepts and principles of bioavailability and bioequivalence of generic medicines if they are to contribute ap-
propriately to generic medicine use. 
Keywords: Generic medicine, Generic substitution, Bioequivalence, Knowledge, Perception, Medical student, 
Yemen 
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1. Introduction 
Utilizing generic medicines in place of their 
brands has been suggested as one area of health 
to reduce annual healthcare expenditure with-
out compromising its delivered quality (1–3). 
Generic medicines are identical, or bioequiva-
lent, to brand medicines in dosage form, safety, 
efficacy, route of administration, quality and in-
tended medical use (4). Production and manu-
facturing of generic medicines start after the 
expiry of the patent on the brand medicine. 
Registration of generic drugs as new products 
and their subsequent marketing require bioe-
quivalence studies. These bioequivalence stud-
ies of generic medicines are mainly based on 
maximum plasma concentration (Cmax) and 
area under the plasma concentration curve 
(AUC) from administration to last observed 
concentration. In Yemen, prior to being intro-
duced to the market, generic medicines have to 
be approved by the Supreme Board for Drugs & 
Medical Appliances (5). For generic medicines 
to be accepted for sale in the Yemeni markets, 
they must be bioequivalent to the reference 
product, and hence, their AUC and Cmax values 
must be within an acceptance range of 0.80–
1.25 of those of the reference product according 
to the U.S. Pharmacopeia, or these generic med-
icines have been accepted by two Middle East 
countries (5).  
The attitudes and perceptions of physicians 
about generic medicines have a great impact on 
utilizing generic medicines through influencing 
patients' behaviors towards generic medicines 
and their prescription rate and use. Information 
given by prescribing doctors on generic medi-
cines influences patients’ acceptance and use of 
these medicines (2, 6–8). The generic medica-
tion prescription rate is improved by physicians 
(9). In the medicine-use-process, physicians are 
the key individuals. They initiate the process by 
prescribing or ordering medicines and follow 
their dispensing by pharmacists. However, in 
most low-income countries, physicians are in-
volved in the dispensing role (10). 
Despite being the key individuals in the med-
icine-use-process, several studies indicated that 
negative attitudes and perceptions of physicians 
about generic medicines’ safety, quality and effi-
cacy influence generic prescribing (2, 4, 9, 11). 
Reasons contributing to the negative attitudes 
and perceptions of physicians about generic 
medicines are attributed to poor knowledge 
about the bioequivalence, lack of confidence and 
misconceptions on generic medicines. Several 
studies indicated that physicians are unaware of 
bioequivalence acceptability criteria for generic 
medicines (4, 12–15). General practitioners, 
who opposed generic prescribing, showed a 
poor confidence towards bioequivalence of ge-
neric medicines to the innovator brands (12). In 
Ireland, a fairly low rate of generic prescribing 
was found compared to England and Northern 
Ireland. The reliability and quality of generic 
medicines were the primary concern of Irish 
prescribers (16) in order to promote cost-
effective prescribing of generic medicines. In 
fact, the misconceptions on generic medicines 
need to be reconsidered and corrected (13–17). 
Several studies in Iraq and Australia on medical 
students’ perceptions regarding generic medi-
cines showed that such misconceptions are at-
tributed to misbeliefs that generic medicines are 
therapeutically identical to their corresponding 
brand medicines (18–19). The suggested reason 
leading to such negative perceptions of medical 
students is that the generic medicine concept is 
not introduced clearly to those students during 
their undergraduate study. To overcome this 
problem, education about the benefits of generic 
prescribing and substitution should be intro-
duced to future medical students, 
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prescribers and dispensers (19). Names of ge-
neric medicines, cost-containment and medi-
cine pricing policy should be incorporated in 
course contents of the pharmacy and medical 
curricula (19). It is noteworthy that local manu-
facturing facilities cannot meet the domestic 
demands, addressing only 10% of such needs, 
while 90% of medicines in the market are im-
ported (20–21). Therefore, it is essential to 
promote generic medicine concept and practice, 
which deem necessary to further measure fu-
ture practitioners' knowledge about generic 
medicines.  
The assessment of final-year medical stu-
dents’ knowledge, attitudes and perceptions 
about generic medicines may have an important 
impact on their use. By studying final-year med-
ical students’ perspectives in Yemen universi-
ties, academics and researchers can formulate 
more efficient interventions to fill in the 
knowledge gap about generic medicines and 
improve their prescribing in the country. To 
date, no studies have been conducted to assess 
the medical students' knowledge and percep-
tions about generic medicines in Sana’a, Yemen. 
Thus, this study will be a key document for poli-
cy makers, legislation, pharmacy and medical 
colleges/universities and future healthcare 
providers. The study was conducted to evaluate 
final-year medical students’ knowledge, atti-
tudes and perceptions about generic medicines 
in Yemen universities. 
2. Methods 
A two-month cross-sectional survey was con-
ducted among final-year medical students in 
three Yemeni universities (Sana'a University, 
the University of Science and Technology and 
Thamar University) in 2013. The study was ap-
proved by the Ethical Committee of the Univer-
sity of Science and Technology. Permission was 
also taken from the relevant universities, and in-
formed consent was obtained from the partici-
pating respondents. The survey questionnaire 
was distributed to the students by the coordina-
tors of academic lectures at each respective uni-
versity. The objectives of the survey were intro-
duced to the students through an explanatory 
letter annexed to the questionnaire. Anonymity 
and confidentiality of respondents were en-
sured. 
Data were collected using a pre-tested, 
structured questionnaire of 22 items. The ques-
tionnaire was divided into four sections: section 
I included four socio-demographic questions 
about age, sex, nationality, scholarship and uni-
versity; section II included four knowledge items 
about the bioequivalence of generic medicines; 
section III included eight questions to evaluate 
understanding of brand medicines versus gener-
ic medicines; and section IV included six ques-
tions to evaluate the perceptions of students 
about current medical and pharmacy education. 
The last three sections used a five-point Likert 
scale (5 = strongly agree, 4 = agree, 3 = neutral, 
2 = disagree and 1 = strongly disagree). 
Face validity of the questionnaire was pilot-
tested by administering it to a sample of ten stu-
dents not involved in the core study. The overall 
Cronbach’s alpha value used to ensure internal 
consistency was 0.80. 
The sampling frame of the study included all 
final-year medical students enrolled in two pub-
lic and one private universities during the study 
period. Their number was obtained from the re-
spective lecture coordinators in each university. 
Descriptive statistics of frequencies and per-
centages were used to summarize raw data ob-
tained by the questionnaire. Differences be-
tween groups were tested by Pearson's chi-
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square or Fisher's exact tests, whenever neces-
sary, at a significance level of <0.05. 
3. Results 
Out of the 270 final-year medical students en-
rolled in the studied public and private univer-
sities, 165 students agreed to participate in the 
present survey. Therefore, the response rate 
was 61.1%. Among the respondents, 104 
(63.0%) were males and 61 (37.0%) were fe-
males, with an average age of 25.6 ± 2.43 years 
old. Yemeni students represented the majority 
(79.4%) of the respondents in the study, 
whereas non-Yemeni students represented only 
20.6% (Table 1). 
Table 1. General characteristics of the final-year medical students 
in Yemeni universities (N=165) 
Characteristic 
 
n (%) 
Mean age (years)    25.6 ±2.43 
 
Sex                            Male 
                                   Female 
104 (63.0) 
61 (37.0) 
 
University               Private 
                                   Governmental 
47 (28.5) 
118 (71.5) 
 
Nationality             Yemeni 
                                   Non-Yemeni 
131 (79.4) 
34 (20.6) 
 
Scholarship           Governmental 
                                  Private 
                                  Other 
86 (52.1) 
56 (33.9) 
23 (13.9) 
3.1. Students' knowledge about bioequiva-
lence 
The responses of the participating students are 
shown in Table (2). More than 50.0% of them 
did not consider that generic medicines are 
therapeutically identical, or equivalent, to the 
compliant brand medicines, or even to each 
other. There was a statistically significant dif-
ference between the responses to the equiva-
lence of generic medicines according to univer-
sities (p=0.019). In addition, more than 60.0% 
of the respondents were not introduced to the 
issues of bioequivalence of generic medicines 
during their study, and more than 80.0% of 
them did not think of the need for more infor-
mation about bioequivalence of generic medi-
cines and its methods of testing. 
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3.2. Students' knowledge about generic ver-
sus brand medicines 
The responses showed that about a half of the 
respondents presumed that a generic medicine 
is not bioequivalent to the corresponding brand 
medicine. More than 60.0% of the participants 
were unaware that the generic medicine must 
be presented in the same dose and dosage form 
as the brand medicine, with a statistically sig-
nificant difference in the responses obtained 
from different universities (p=0.027). With re-
gard to quality and efficacy, about 63.0% of the 
respondents thought that generic medicines are 
of lower quality (80.0%), are less effective 
(58.0%) produce more side-effects (47.8%) and 
adhere to lower safety standards (72.6%) than 
brand medicines, with a statistically significant 
difference in the responses to the question 
about the safety standards between the differ-
ent universities (p=0.026). With respect to the 
question about the price of generic medicines, 
82.6% of the respondents did not believe that 
generic medicines are less expensive than 
brand medicines (Table 3). 
3.3. Students' perception of the current pre-
scribing education 
Table (4) showed the responses of the medical 
students about the current prescribing educa-
tion, where a statistically significant difference 
(p=0.016) in the responses related to the re-
spondents' needs for more information on is-
sues pertaining to the safety and efficacy of ge-
neric medicines was found. Of the respondents, 
46.6% (64/165) felt non-confident enough to 
prescribe medicines according to generic 
names instead of their brand medicines. A sta-
tistically significant difference (p=0.036) was 
found in the confidence of generic prescribing 
according to the variable of nationality. About a 
half of the respondents thought that it is more 
difficult to recall a medicine’s therapeutic class 
using its generic compared to the brand name, 
and 79.4% of them did not believe that pharma-
cists would give them advice in the future with 
regard to generic medicines. Approximately 
57% of the respondents either disagreed or 
strongly disagreed that their future prescribing 
habits will be influenced by their senior col-
leagues and medical consultants. Moreover, 
more than a half of the respondents (52.5%) did 
not believe that advertisements by drug compa-
nies will influence their future prescribing pat-
terns. The responses showed that about 45.0% 
of the respondents considered that their univer-
sities do not exert adequate efforts and focus on 
cost-effective prescribing in their medical cur-
ricula, with a statistically significant difference 
in the responses according to sex. 
4. Discussion 
Considering the importance of generic medicine 
use, especially in low- and middle-income coun-
tries, the present study is the first study to as-
sess final-year medical students’ knowledge and 
perceptions about generic medicines in Yemeni 
universities. 
The term "generic medicine" has been de-
fined by several public and private health organ-
izations in the world. The World Health Organi-
zation defined the generic medicine as ‘a phar-
maceutical product, usually intended to be inter-
changeable with an innovator product that is 
manufactured without a license from the innova-
tor company and marketed after the expiry date 
of the patent or other exclusive rights’ (22). Un-
der the Food and Drug Administration’s regula-
tions, a generic medicine must contain identical 
amounts of the same active ingredients in the 
same dosage form, safety, strength, route of ad-
ministration and intended use as a branded 
medicine (23). 
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In the present study, only 28.1% of the fi-
nal-year medical students were aware of the 
differences between generic and brand medi-
cines and 21.5% of them were aware of the 
therapeutic bioequivalence to each other. This 
could be mainly due to the lack of knowledge 
about these products and their relationship to 
each other, where 61.8% of the respondents 
were not introduced to the issues of bioequiva-
lence for generic drugs during their education. 
Similar findings were reported for Australian 
and Iraqi final-year medical students (18, 19), 
where 72.0 and 75.0% of the students did not 
believe that generic medicines are therapeuti-
cally equivalent to their corresponding brand 
medicines, respectively. Compared to only 8.7% 
of the respondents in the present study who 
showed a need for information about the bioe-
quivalence of generic medicines during their 
medical education, 68.0% and 75.0% of Aus-
tralian and Iraqi medical students showed such 
a need, respectively. This is may be due to the 
lack of importance of generic drugs among stu-
dents in the Yemeni universities. 
As regard to the understanding of students 
about generic versus brand medicines, only 
14.4% believed that generic medicines must 
contain the same dose as the brand medicine. 
Most of the students agreed that generic medi-
cines are of lower quality (81.3%) and less ef-
fective (58.0%) than brand medicines. These 
findings are in disagreement with those report-
ed among Australian and Iraqi students, where 
53.0% and 45.0% of medical students, respec-
tively, believed that both generic and brand 
medicines have nearly the same dose. However, 
in both latter studies, students agreed that ge-
neric medicines have a lower quality in compar-
ison to brand medicines (93.0% and 68.0%, re-
spectively). When considering the cost of drugs, 
82.8% of the students did not expect generic 
medicines to be cheaper than brand ones. This 
is in contrast to the findings from Australia and 
Iraq, being reported among 2.8 and 6.0% of the 
students, respectively. 
Despite the above-mentioned findings, only 
12.4% of the medical students in Yemeni uni-
versities showed their need for more infor-
mation regarding the safety and efficacy of ge-
neric medicines, and 28.3% of them felt confi-
dent in prescriptions written by generic medi-
cines rather than brand ones. A small proportion 
of students (7.6%) stated that pharmacists are 
one of the important healthcare professionals to 
give advice on generic medicines. This may in-
fluence the prescribing patterns of the future 
practitioners. 
Regarding the prescribing education, 45.0% 
of the students did not believe that the topic of 
cost-effective prescribing was well covered in 
their medical education. This is in line with the 
studies conducted in Australia and Iraq (18, 19). 
This may have a negative impact on the stu-
dents' prescription habits while practicing upon 
graduation. 
Overall, there were statistically significant 
differences between students in different uni-
versities regarding the items of questionnaire, 
and this may reflect the different curricula pro-
vided by the three universities involved in the 
study. However, there was no statistically signif-
icant difference between the responses of males 
and females in the present study. It is notewor-
thy that a limitation of the present study is that 
only three out of ten public and private medical 
schools were included in this study. Thus, there 
should be further studies involving all universi-
ties to provide stronger evidence to the gov-
ernment to adopt the issues of generic medi-
cines in Yemen. 
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5. Conclusions 
This study concludes the lack of knowledge 
about the bioequivalence and cost of generic 
medicines among medical students in Yemeni 
universities. The issues concerning generic 
medicines should be fully introduced to the 
medical students during their study to encour-
age them to start prescribing generic medicines 
during work practice. In addition, there should 
be a national strategy towards the use of gener-
ic medicines to be adopted by the government 
in Yemen. This strategy may provide an oppor-
tunity to reduce the cost of healthcare and to 
save money for use in improving access to med-
icines and other healthcare services in Yemen.  
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